Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05962879 · ClinicalTrials.gov registry record · NA

Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness

A NA study of Anxiety Disorders and Depressive Disorder, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT05962879 is a NA study of Anxiety Disorders and Depressive Disorder that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 70 participants, below the 1,139-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05962879, a NA study of Anxiety Disorders and Depressive Disorder, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

This research study aims to develop a brief group-based treatment called Resilience Training for Teens, then to test how well it protects high school students with mild symptoms of depression, anxiety, or having unusual feelings from developing mental illnesses.

Interventions

  • BEHAVIORAL Resilience Training for Teens

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2024-03-22
Est. Completion 2027-07-31
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT05962879

The ClinicalTrials.gov registry entry for NCT05962879 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,139-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (94% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Anxiety Disorders appearing as the primary indexed condition, and to 1 intervention - of which Resilience Training for Teens is the first listed.

NCT05962879 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05962879 about?

NCT05962879 is a clinical study titled "Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness". This research study aims to develop a brief group-based treatment called Resilience Training for Teens, then to test how well it protects high school students with mild symptoms of depression, anxiety, or having unusual feelings from developing mental illnesses.

What is the current status of trial NCT05962879?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2024-03-22. Estimated completion is 2027-07-31.

What conditions does trial NCT05962879 study?

This clinical trial studies the following conditions: Anxiety Disorders, Depressive Disorder, Psychotic Disorders, Psychosocial Functioning.

What interventions are being tested in trial NCT05962879?

The interventions under investigation include: Resilience Training for Teens (BEHAVIORAL).

Who is sponsoring clinical trial NCT05962879?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05962879 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.